Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tolerability”

21,706 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21,706 results

Early research (Phase 1)Study completedNCT07787624
What this trial is testing

Phase 1 Clinical Study of MWN109 Injection in Healthy Chinese Volunteers

Who this might be right for
Healthy Volunteers
Shanghai Minwei Biotechnology Co., Ltd 48
Early research (Phase 1)Temporarily pausedNCT06649682
What this trial is testing

68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 20
Early research (Phase 1)Study completedNCT03836859
What this trial is testing

Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Dompé Farmaceutici S.p.A 30
Early research (Phase 1)Study completedNCT03934359
What this trial is testing

Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai De Novo Pharmatech Co., Ltd. 19
Early research (Phase 1)Study completedNCT03239379
What this trial is testing

A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects

Who this might be right for
Safety and Tolerability in Healthy Subjects
Bioniz Therapeutics 32
Early research (Phase 1)Study completedNCT03273088
What this trial is testing

Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects

Who this might be right for
Phase 1Bioequivalence
AryoGen Pharmed Co. 34
Early research (Phase 1)Study completedNCT06092788
What this trial is testing

Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose

Who this might be right for
Healthy
ATXA Therapeutics Limited 13
Early research (Phase 1)Study completedNCT00783003
What this trial is testing

Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT05028127
What this trial is testing

Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects

Who this might be right for
Healthy Volunteers
UCB Celltech 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06004661
What this trial is testing

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 23
Early research (Phase 1)Study completedNCT03798561
What this trial is testing

Study to Evaluate ASN008 Topical Gel (TG)

Who this might be right for
Dermatitis, AtopicPruritusDermatitis Eczema
Asana BioSciences 24
Early research (Phase 1)Study completedNCT04925661
What this trial is testing

HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia

Who this might be right for
Chronic Kidney DiseasesRenal Anemia
Sunshine Lake Pharma Co., Ltd. 40
Not applicableStudy completedNCT03834142
What this trial is testing

NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries

Who this might be right for
Acute PainArthropathy of KneeArthropathy of Hip+3 more
Jacques E. Chelly 20
Testing effectiveness (Phase 2)Study completedNCT02054286
What this trial is testing

Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

Who this might be right for
HIV Infection
Theravectys S.A. 38
Early research (Phase 1)Study completedNCT01272973
What this trial is testing

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 96
Testing effectiveness (Phase 2)Looking for participantsNCT07222969
What this trial is testing

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Vibrant Sciences Limited 146
Early research (Phase 1)Study completedNCT07242469
What this trial is testing

A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 53
Early research (Phase 1)Study completedNCT03213405
What this trial is testing

Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV

Who this might be right for
Respiratory Syncytial Virus Infections
Pontificia Universidad Catolica de Chile 24
Testing effectiveness (Phase 2)Study completedNCT06102005
What this trial is testing

Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma

Who this might be right for
Asthma
Sanofi 685
Early research (Phase 1)Active Not RecruitingNCT07021066
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

Who this might be right for
Gastric AdenocarcinomaAdvanced Pancreatic Ductal AdenocarcinomaEsophageal Adenocarcinoma+2 more
SystImmune Inc. 160
Next Page